Butyrate as a differentiating agent: pharmacokinetics, analogues and current status

Cancer Letters

Volumn 78, Issue 1-3, 1994, Pages 1-5

  Newmark, Harold L ^a,b   Lupton, Joanne R ^c   Young, Charles W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Memorial Hospital   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Butyramide; Butyrate; Butyrate esters; Tributyrin

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; DRUG ANALOG;

CELL DIFFERENTIATION; DRUG ACTIVITY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SICKLE CELL ANEMIA; THALASSEMIA; TUMOR CELL;

ANEMIA, SICKLE CELL; ANTINEOPLASTIC AGENTS; BUTYRATES; CELL DIFFERENTIATION; HUMAN; LEUKEMIA; THALASSEMIA;

EID: 0028260120     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(94)90023-X     Document Type: Review

References (28)

1. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells
2. Effect of sodium butyrate on mammalian cells in culture: a review
3. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds
4. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
5. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60
6. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching
7. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC
8. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta-thalassemia
9. Sodium-N-butyrate induces cytoskeletal rearrangements and formation of cornified envelopes in cultured adult human keratinocytes
10. Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child
11. Clinical pharmacology of sodium butyrate in patients with acute leukemia
12. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders
13. Short chain fatty acids in human large intestine, portal, hepatic and venous blood
14. Composition of Foods: Dairy and Egg Products
15. Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis
16. Effects of differing concentrations of sodium butyrate on 1,2-dimethylhydrazine-induced rat intestine neoplasia
17. 3
18. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts
19. Butyramide and monobutyrin: growth inhibitory and differentiating agents
20. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies
21. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation
22. Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate
23. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate
24. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells
25. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy
26. Pharmacokinetic studies of N-butyric acid mono- and polyesters derived from monosaccharides
27. Derivatives of butyric acid as potential anti-neoplastic agents
28. Novel anticancer prodrugs of butyric acid. 2